Question: Which publication covers a broader range of topics, Cigar Aficionado or Our State?

Context articles: La Flor Dominicana
Fuente Fuente OpusX
Cigar Aficionado
Drew Nieporent
Graycliff (cigar brand)
Marvin Shanken
Our State
Cigar boom
James Suckling
Epoxygenase

La Flor Dominicana (Dominican Flower) is a "boutique-style" cigar brand manufactured by Tabacalera La Flor S.A., a company started in 1996 in Santiago, the Dominican Republic.
 The company was started and is currently owned by cigar maker Litto Gomez Diez, who was called by Cigar Aficionado "arguably the most innovative mind in the cigar business."
 Gomez, a jeweler-turned-cigar maker started the business after his jewellery store in Miami was robbed by armed men at gunpoint of about $400,000 worth of jewellery.
 Today the company's factory is based in Tamboril, in the Dominican Republic.
Fuente Fuente OpusX is the premier cigar line in the Arturo Fuente Cigar family.
 Made by Tabacalera A. Fuente, this cigar is consistently ranked as the single most sought-after cigar in the world by "Cigar Aficionado".
 Fuente Fuente OpusX cigars are wrapped in Rosado leaves which are grown in the Chateau de la Fuente plantation in a tropic river valley in the Dominican Republic.
 The Opus name is derived from its unique Rosado leaf wrapper.
Cigar Aficionado is an American magazine that is dedicated to the world of cigars.
 Published since September 1992, the magazine is known for its articles about different brands of cigars worldwide, and for the celebrities that have appeared on its cover.
 It is also noted for its opposition to the Cuban embargo.
 The magazine was launched by Marvin R. Shanken's M. Shanken Communications, the publisher of "Wine Spectator" magazine since 1976.
 The current editor is David Savona.
Drew Nieporent is a New York City restaurateur.
 His company Myriad Restaurant Group owns and operates numerous restaurants, many of which are known for their celebrity clientele, and in some cases celebrity co-owners.
 Many are known for their difficulty in obtaining reservations.
 In an interview with "Cigar Aficionado", Nieporent recalled turning down Henry Kissinger.
The Graycliff Cigar Company produces cigars out of the historic Graycliff Inn in Nassau, The Bahamas.
 The company was founded by estate owner Enrico Garzaroli and cigar aficionado Avelino Lara during the late 20th century.
Marvin R. Shanken (born October 4, 1943) is an American publisher and founder of M. Shanken Communications.
 Shanken's roster of lifestyle publications includes "Wine Spectator", "Cigar Aficionado" and "Whisky Advocate".
 Based in Manhattan, M. Shanken Communications' headquarters store thousands of bottles of wine for tasting and review.
Our State (full title: Our State: Down Home in North Carolina) is a monthly magazine based in Greensboro, North Carolina, featuring travel and history articles and photographs about North Carolina people, places and events.
 First published in 1933 as "The State" magazine, the publication has become "the oldest regional publication of its kind in the country," according to the Associated Press.
 It is a member of the City and Regional Magazine Association (CRMA).
The Cigar Boom is the name given to the resurgence of cigar consumption in the United States during the mid-1990s.
 Beginning in 1992, imports and sales of premium cigars began to rise dramatically and manufacturers struggled to keep up with demand, leading to industry-wide shortages of raw materials and finished products.
 The period was marked and the trend accelerated with the 1992 establishment of "Cigar Aficionado" magazine.
James Suckling (born September 29, 1958) is an American wine and cigar critic and former Senior Editor and European Bureau Chief of "Wine Spectator" as well as European Editor of "Cigar Aficionado".
 Suckling is internationally regarded as one of the world's most influential wine critics, and one of the most experienced critics of vintage cigars.
Epoxygenases are a set of membrane-bound, heme-containing cytochrome P450 (CYP P450 or just CYP) enzymes that metabolize polyunsaturated fatty acids to epoxide products that have a range of biological activities.
 The most thoroughly studied substrate of the CYP epoxylgenases is arachidonic acid.
 This polyunsaturated fatty acid is metabolized by cyclooxygenases to various prostaglandin, thromboxane, and prostacyclin metabolites in what has been termed the first pathway of eicosanoid production; it is also metabolized by various lipoxygenases to hydroxyeicosatetraenoic acids (e.g. 5-Hydroxyeicosatetraenoic acid, 12-Hydroxyeicosatetraenoic acid, 15-hydroxyicosatetraenoic acid) and leukotrienes (e.g. leukotriene B4, leukotriene C4) in what has been termed the second pathway of eicosanoid production.
 The metabolism of arachidonic acid to epoxyeicosatrienoic acids by the CYP epoxygenases has been termed the third pathway of eicosanoid metabolism.
 Like the first two pathways of eicosanoid production, this third pathway acts as a signaling pathway wherein a set of enzymes (the epoxygenases) metabolize arachidonic acid to a set of products (the eicosatrienoic acid epoxides, abbreviated as EETs, which are classified as nonclassic eicosanoids) that act as secondary signals to work in activating their parent or nearby cells and thereby orchestrate functional responses.
 However, none of these three pathways is limited to metabolizing arachidonic acid to eicosanoids.
 Rather, they also metabolize other polyunsaturated fatty acids to products that are structurally analogous to the eicosanoids but often have different bioactivity profiles.
 This is particularly true for the CYP epoxygenases which in general act on a broader range of polyunsaturated fatty acids to form a broader range of metabolites than the first and second pathways of eicosanoid production.
 Furthermore, the latter pathways form metabolites many of which act on cells by binding with and thereby activating specific and well-characterized receptor proteins; no such receptors have been fully characterized for the epoxide metabolites.
 Finally, there are relatively few metabolite-forming lipoxygenases and cyclooxygenases in the first and second pathways and these oxygenase enzymes share similarity between humans and other mammalian animal models.
 The third pathway consists of a large number of metabolite-forming CYP epoxygenases and the human epoxygenases have important differences from those of animal models.
 Partly because of these differences, it has been difficult to define clear roles for the epoxygenase-epoxide pathways in human physiology and pathology.